Oxazinanes
Medchemexpress LLC 11β-HSD1-IN-8 | 386704-15-0 | MFCD01862654 | 95.0% | 247.17 | C10H8F3NO3 | 250 MG
11β-HSD1-IN-8 is a small-molecule inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) with a reported IC50 of 2.3 μM for the human enzyme. Supplied as a high-purity solid research reagent, it is intended for in vitro studies of metabolic and cognitive disorders such as diabetes and cognitive decline.
- Selective inhibition of 11β-HSD1 (IC50 2.3 μM).
- Intended for in vitro research of metabolic and cognitive disorders.
- High stated purity of 95.0%.
- Solid form; off-white to light yellow appearance.
- Storage: powder stable at -20°C (3 years) or 4°C (2 years).
- Molecular formula C10H8F3NO3; molecular weight 247.17.
![eMolecules 1354351-56-6 | (R)-tert-Butyl azepan-3-ylcarbamate | Combi-Blocks | MFCD19686115 | 214.309 | C11H22N2O2 | 97.000 | CC(C)(C)OC(=O)N[C@@H]1CCCCNC1 | 5g | 457918329](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502697425.jpg-250.jpg)
eMolecules 1354351-56-6 | (R)-tert-Butyl azepan-3-ylcarbamate | Combi-Blocks | MFCD19686115 | 214.309 | C11H22N2O2 | 97.000 | CC(C)(C)OC(=O)N[C@@H]1CCCCNC1 | 5g | 457918329
(R)-tert-Butyl azepan-3-ylcarbamate | Combi-Blocks | 1354351-56-6 | MFCD19686115 | 214.309 | C11H22N2O2 | 97.000 | CC(C)(C)OC(=O)N[C@@H]1CCCCNC1 | 5g | 457918329
TARGETMOL CHEMICALS INC PF-3758309 HYDROCHLORIDE 10MG
Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. PF-3758309 hydrochloride (PF-03758309 hydrochloride) is a PAK4 inhibitor is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PF-3758309 hydrochloride binds to PAK4 inhibiting PAK4 activity and cancer cell growth. PAK4 a serine/threonine kinase belonging to the p21-activated kinase (PAK) family is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility proliferation and survival. purity: 98%